Vaccine nationalism is already a concern as countries jockey to secure doses of future shots, desperate for a way out of a global crisis that’s slammed their economies.
J&J announced in June that it had accelerated vaccine trials with ambitions of launching human studies in mid-July. The company will dose its first patients on 22 July in Belgium.
The health ministry reiterated that states needed to take ownership of the Covid fight. It also said India's mortality currently stood at 2.6 per cent.
According to Sechenov University's Alexander Lukashev, the objective of the trial was to show the vaccine's safety for human health, which was successfully done.
Two peer-reviewed studies have shown a pattern of reduced mortality from Covid among BCG-vaccinated countries, but epidemiologists don’t think evidence is strong
Nobody is safe in a market where competition is stunted and choice limited. For the industry, meaningful reform will have to start with the government itself.
Data shows re-alignment in India’s exports, with Tamil Nadu & Telangana posting strong growth in 2024-25 as traditional heavyweights Gujarat & Maharashtra see declines. Gujarat still leads, though.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS